Earnings delivered despite slower market procedure volume and supply recovery; Growth driven by TAVR, Pacing, U.S. Core Spine, and International Diabetes DUBLIN, Nov. 22, 2022 /PRNewswire/ — Medtronic plc (NYSE:MDT) today announced financial results for its second quarter of fiscal year 2023, which ended October 28, 2022. Key Highlights Revenue of $7.6 billion decreased 3% […]
Other News
Fujifilm’s ARIETTA 650 DeepInsight™ Ultrasound System Now in Clinical Use at Multiple United Medical Imaging Healthcare Facilities
Lexington, Mass., Nov. 22, 2022 (GLOBE NEWSWIRE) — FUJIFILM Healthcare Americas Corporation, a leading provider of diagnostic and enterprise imaging solutions, announced that United Medical Imaging Healthcare (Los Angeles, CA) has begun installing Fujifilm’s new ARIETTA 650 DeepInsight™ ultrasound systems in several of its radiology facilities throughout southern California as part of a volume […]
Canon Medical Systems Showcases Meaningful Innovation in its Suite of Solutions and Products at RSNA 2022
Canon Highlights Latest Innovations with Interactive Digital Booth Experience and the Final Tour Stop of The Canon Across America Mobile Tour at McCormick Place Tustin, California, Nov. 22, 2022 (GLOBE NEWSWIRE) — Canon Medical Systems USA, Inc., a global leader in innovative diagnostic imaging technology, is proud to announce that it […]
Tenaya Therapeutics Announces Closing of Public Offering
SOUTH SAN FRANCISCO, Calif., Nov. 21, 2022 (GLOBE NEWSWIRE) — Tenaya Therapeutics, Inc. (Nasdaq: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies that address the underlying causes of heart disease, announced today the closing of its previously announced underwritten public offering of […]
Teledyne DALSA announces its new line of high-performance X-ray detectors at RSNA 2022
New Axios IGZO-based X-ray detectors deliver an unrivaled balance of performance and value WATERLOO, Ontario, Nov. 22, 2022 (GLOBE NEWSWIRE) — Teledyne DALSA is pleased to announce its presence at the RSNA 2022 Technical Exhibition with a new offering of X-Ray detectors based on Indium Gallium Zinc Oxide (IGZO) in addition to […]
Acticor Biotech: World’s First Clinical Trial to Test New Drug Glenzocimab for Heart Attacks
PARIS–(BUSINESS WIRE)–Partnership between the University of Birmingham and Acticor Biotech (Paris:ALACT) will see patients with heart attacks treated with glenzocimab, a promising new class of drug for the first time. A potential new drug to improve the long-term outcomes for heart attack patients will be trialled in the UK. With the signing […]
Tufts Medical Center Neurosurgeons and CereVasc Co-founders Honored by the Society of Vascular and Interventional Neurology for Innovation in Hydrocephalus Treatment
BOSTON, Nov. 21, 2022 /PRNewswire/ — Tufts Medical Center neurosurgeons Adel Malek, MD, PhD, Chief of Neurovascular Surgery, and Carl Heilman, MD, Neurosurgeon-in-Chief and Chairman of Neurosurgery, both Co-Founders of CereVasc, Inc. have been honored with the 2022 Innovation Award at the annual meeting of the Society of Vascular and Interventional Neurology (SVIN), for […]
UW–Madison To Perform the First U.S. Evaluation of GE Healthcare’s Photon Counting CT Technology with Deep Silicon Detectors
GE Healthcare’s design for Deep Silicon detectors for a photon counting CT (PCCT) is engineered with the goal of achieving breakthroughs in both CT spatial and spectral resolution at the same time and increasing imaging performance across care areas Researchers at the University of Wisconsin–Madison will kick off research scanning […]
New AF and Congenital Heart Disease Data on Vektor Medical’s vMap® Presented at the 15th Asia Pacific Heart Rhythm Society Scientific Session
SAN DIEGO–(BUSINESS WIRE)–Vektor Medical, developer of the world’s first technology to rapidly map cardiac arrhythmias using only 12-lead ECG data, today announced it presented new data on its vMap® technology that demonstrated potential utility in patients with adult congenital heart disease (ACHD) and refractory atrial fibrillation (AF) at the recent 15th Annual […]
Peer-Reviewed Study Finds That Masimo SET® Pulse Oximetry Has No Clinically Significant Difference in Accuracy or Bias Between Black and White People
IRVINE, Calif.–(BUSINESS WIRE)–Masimo (NASDAQ: MASI) today announced the publication of a peer-reviewed study regarding Masimo SET® pulse oximetry performance in varying skin pigmentation in the Journal of Clinical Monitoring and Computing. The retrospective trial, “Racial effects on Masimo pulse oximetry: a laboratory study,” by Drs. Steven J. Barker and Wilson C. Wilson, found that there was […]



